Key Insights

Highlights

Success Rate

76% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

10.5%

6 terminated out of 57 trials

Success Rate

76.0%

-10.5% vs benchmark

Late-Stage Pipeline

7%

4 trials in Phase 3/4

Results Transparency

16%

3 of 19 completed with results

Key Signals

3 with results76% success

Data Visualizations

Phase Distribution

46Total
Not Applicable (27)
Early P 1 (2)
P 1 (3)
P 2 (10)
P 3 (1)
P 4 (3)

Trial Status

Completed19
Unknown16
Recruiting8
Terminated6
Withdrawn3
Not Yet Recruiting3

Trial Success Rate

76.0%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (57)

Showing 20 of 20 trials
NCT06141668Not ApplicableCompletedPrimary

Optimal Stimulation Parameters to Disrupt Epileptiform Activity

NCT07546253Not Yet Recruiting

Post-Market Real-World Evidence Registry for the NeuroOne OneRF® Ablation System for Epilepsy

NCT04770337Not ApplicableCompletedPrimary

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

NCT06425029Not ApplicableRecruiting

Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application

NCT07305311Not ApplicableNot Yet RecruitingPrimary

Characterising the Network-Specific Effects of Piriform Cortex Stimulation Via SEEG

NCT05493722Early Phase 1RecruitingPrimary

Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy

NCT05292183Not ApplicableCompletedPrimary

Modulation of Emotion Perception in Humans Via Amygdala Stimulation

NCT06304389Not ApplicableRecruitingPrimary

Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy

NCT05019885Phase 2Recruiting

The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy

NCT06575413Not ApplicableCompletedPrimary

Investigating the Role and Electrophysiological Characteristics of the Human Claustrum Based on SEEG

NCT06524479Not ApplicableRecruitingPrimary

Investigating the Functional Characteristics During Wakefulness and Sleep Based on SEEG

NCT06396494Active Not Recruiting

An Automated Navigation System for Deep Brain Electrode Implantation

NCT06387186Phase 1Not Yet RecruitingPrimary

Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy

NCT03644732RecruitingPrimary

Atlas of Human Cognition by SEEG (MAPCOG-SEEG)

NCT04153175Phase 2TerminatedPrimary

Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

NCT05232630Phase 4RecruitingPrimary

Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes

NCT06241963Not ApplicableRecruiting

High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Refractory Epilepsy

NCT04218812Not ApplicableActive Not Recruiting

Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation

NCT03196934UnknownPrimary

Expanded Use of Cannabidiol Oral Solution

NCT04684797Not ApplicableUnknownPrimary

Localization of the Reward Positivity to ACC

Scroll to load more

Research Network

Activity Timeline